Amikacin Liposomal/Neb.Accessr
Brand name: Arikayce
Rank #254 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$50.5M
Total Cost
3,394
Total Claims
$50.5M
Total Cost
178
Prescribers
$15K
Cost per Claim
130
Beneficiaries
3,533
30-Day Fills
$284K
Avg Cost/Provider
19
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$50.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $50.5M total
🔎 Data Overview
At $14,891 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $283,937 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $388,775 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Amikacin Liposomal/Neb.Accessr
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jared Eddy | Infectious Disease | Denver, CO | 88 | $1.3M |
| 2 | Pamela Mcshane | Pulmonary Disease | Tyler, TX | 79 | $1.2M |
| 3 | Fernando Alvarado | Infectious Disease | Altamonte Springs, FL | 76 | $1.2M |
| 4 | Rajesh Agrawal | Pulmonary Disease | Pinellas Park, FL | 74 | $1.1M |
| 5 | Andrew Dold | Infectious Disease | Dacula, GA | 73 | $1.1M |
| 6 | David Griffith | Pulmonary Disease | Denver, CO | 67 | $972K |
| 7 | Archana Shah | Infectious Disease | Winter Park, FL | 55 | $815K |
| 8 | Amardeep Sodhi | Infectious Disease | Peoria, AZ | 48 | $726K |
| 9 | Ashwin Basavaraj | Pulmonary Disease | New York, NY | 46 | $680K |
| 10 | Thuan Le | Infectious Disease | Murrieta, CA | 43 | $637K |
| 11 | Rabeeya Sabzwari | Infectious Disease | Maywood, IL | 41 | $621K |
| 12 | Anas Hadeh | Pulmonary Disease | Weston, FL | 42 | $608K |
| 13 | Poppy Markwell | Infectious Disease | New Orleans, LA | 40 | $601K |
| 14 | Maria Tupayachi Ortiz | Internal Medicine | Miami, FL | 37 | $589K |
| 15 | Pushpalatha Arakere | Infectious Disease | Fresno, CA | 38 | $571K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 251 | Sodium,calcium,mag,pot Oxybate (Xywav) | $51.1M | 3,234 |
| 252 | Eslicarbazepine Acetate (Aptiom) | $51.1M | 31,472 |
| 253 | Risdiplam (Evrysdi) | $51.1M | 1,891 |
| 254 | Amikacin Liposomal/Neb.Accessr (Arikayce) | $50.5M | 3,394 |
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology